end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccretionAmortizationOfDiscountsAndPremiumsInvestments,AccruedEmployeeBenefitsCurrent,AccruedLiabilitiesCurrent,AccruedProfessionalFeesCurrent,AccruedRentCurrent,AccruedRentNoncurrent,AccruedRoyaltiesCurrent,AccruedRoyaltiesCurrentAndNoncurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapitalCommonStock,AllocatedShareBasedCompensationExpense,AmortizationOfFinancingCosts,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,AreaOfLand,AreaOfLand,AreaOfLand,Assets,AssetsCurrent,AssetsHeldForSaleCurrent,AssetsHeldForSalePropertyPlantAndEquipment,AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent,AvailableForSaleSecurities,AvailableForSaleSecuritiesAmortizedCost,AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue,AvailableForSaleSecuritiesCurrent,AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost,AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost,AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue,AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue,AvailableForSaleSecuritiesFairValueDisclosure,AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds,AvailableForSaleSecuritiesGrossUnrealizedGains,AvailableForSaleSecuritiesGrossUnrealizedLoss,AvailableForSaleSecuritiesGrossUnrealizedLosses1,AvailableforsaleSecuritiesGrossUnrealizedGain,BusinessAcquisitionCostOfAcquiredEntityCashPaid,BusinessAcquisitionCostOfAcquiredEntityPurchasePrice,BusinessAcquisitionCostOfAcquiredEntityTransactionCosts,Cash,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsPeriodIncreaseDecrease,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CashEquivalentsAtCarryingValue,CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations,CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations,CommitmentsAndContingencies,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockDividendsPerShareCashPaid,CommonStockDividendsPerShareDeclared,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,CurrentFederalTaxExpenseBenefit,CurrentForeignTaxExpenseBenefit,CurrentIncomeTaxExpenseBenefit,CurrentStateAndLocalTaxExpenseBenefit,DebtConversionConvertedInstrumentSharesIssued1,DebtInstrumentConvertibleConversionPrice1,DebtInstrumentInterestRateStatedPercentage,DebtInstrumentRepurchasedFaceAmount,DeferredCompensationLiabilityCurrent,DeferredCompensationPlanAssets,DeferredFederalStateAndLocalTaxExpenseBenefit,DeferredIncomeTaxExpenseBenefit,DeferredOfferingCosts,DeferredTaxAssetsCapitalLossCarryforwards,DeferredTaxAssetsGross,DeferredTaxAssetsInProcessResearchAndDevelopment,DeferredTaxAssetsInvestments,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsLiabilitiesNetCurrent,DeferredTaxAssetsLiabilitiesNetNoncurrent,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal,DeferredTaxAssetsOther,DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax,DeferredTaxAssetsTaxCreditCarryforwardsResearch,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilities,DeferredTaxLiabilitiesTaxDeferredIncome,DeferredTaxLiabilitiesUndistributedForeignEarnings,DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities,DefinedContributionPlanEmployerDiscretionaryContributionAmount,DefinedContributionPlanEmployerMatchingContributionPercent,DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent,DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent,Depreciation,DepreciationAndAmortization,DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax,DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax,DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation,DisposalGroupIncludingDiscontinuedOperationRevenue,DividendsCommonStock,DividendsCommonStockCash,DividendsCommonStockStock,DividendsPayableAmountPerShare,DividendsPayableCurrent,DividendsPayableCurrentAndNoncurrent,DueFromRelatedPartiesCurrent,DueToRelatedPartiesCurrentAndNoncurrent,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationTaxCredits,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,ForeignIncomeTaxExpenseBenefitContinuingOperations,FutureMinimumSubleaseRentalsSaleLeasebackTransactions,FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter,FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFourYears,FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear,FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears,FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears,GainLossOnContractTermination,GainLossOnDispositionOfAssets,GainLossOnDispositionOfProperty,GainLossOnRepurchaseOfDebtInstrument,GainsLossesOnExtinguishmentOfDebt,ImpairmentOfInvestments,ImpairmentOfLongLivedAssetsHeldForUse,IncomeLossFromContinuingOperations,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,IncomeLossFromContinuingOperationsPerBasicAndDilutedShare,IncomeLossFromContinuingOperationsPerBasicShare,IncomeLossFromContinuingOperationsPerDilutedShare,IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity,IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare,IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare,IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare,IncomeTaxExpenseBenefit,IncomeTaxExpenseBenefitContinuingOperations,IncomeTaxesPaid,IncomeTaxesReceivable,IncomeTaxesReceivableNoncurrent,IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance,IncomeTaxReconciliationChangeInEnactedTaxRate,IncomeTaxReconciliationDispositionOfBusiness,IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate,IncomeTaxReconciliationNondeductibleExpense,IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost,IncomeTaxReconciliationOtherAdjustments,IncomeTaxReconciliationRepatriationOfForeignEarnings,IncomeTaxReconciliationStateAndLocalIncomeTaxes,IncomeTaxReconciliationTaxCreditsResearch,IncomeTaxReconciliationTaxExemptIncome,IncreaseDecreaseInAccountsPayableTrade,IncreaseDecreaseInDeferredIncomeTaxes,IncreaseDecreaseInEmployeeRelatedLiabilities,IncreaseDecreaseInLongTermReceivablesCurrent,IncreaseDecreaseInOperatingCapital,IncreaseDecreaseInOtherAccruedLiabilities,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInOtherOperatingCapitalNet,IncrementalCommonSharesAttributableToConversionOfDebtSecurities,IncrementalCommonSharesAttributableToShareBasedPaymentArrangements,InterestExpense,InterestOnConvertibleDebtNetOfTax,InterestPaid,InterestPaidNet,InterestPayableCurrent,InvestmentIncomeNet,LeaseAndRentalExpense,LeaseholdImprovementsGross,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LiabilityForUncertainTaxPositionsNoncurrent,LongTermNotesPayable,MachineryAndEquipmentGross,MarketableSecurities,MarketableSecuritiesCurrent,MarketableSecuritiesGainLoss,MarketableSecuritiesNoncurrent,MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments,MoneyMarketFundsAtCarryingValue,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetIncomeLoss,NetIncomeLossAttributableToParentDiluted,NetIncomeLossAvailableToCommonStockholdersBasic,NotesPayable,NotesPayableCurrent,NotesPayableFairValueDisclosure,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseExpense,OperatingLeasesFutureMinimumPaymentsDue,OperatingLeasesFutureMinimumPaymentsDueCurrent,OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals,OperatingLeasesFutureMinimumPaymentsDueInFiveYears,OperatingLeasesFutureMinimumPaymentsDueInFourYears,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLeasesFutureMinimumPaymentsDueThereafter,OperatingLeasesFutureMinimumPaymentsReceivable,OperatingLeasesIncomeStatementSubleaseRevenue,OperatingLeasesRentExpenseSubleaseRentals1,OperatingLossCarryforwards,OtherAccruedLiabilitiesCurrent,OtherAssetsCurrent,OtherAssetsNoncurrent,OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent,OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease,OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax,OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent,OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax,OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,OtherGeneralAndAdministrativeExpense,OtherLiabilitiesNoncurrent,OtherMarketableSecuritiesCurrent,OtherNoncashIncomeExpense,OtherNonoperatingIncome,OtherNonoperatingIncomeExpense,OtherReceivablesNetCurrent,OtherRestructuringCosts,OtherSalesRevenueNet,OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent,PaymentsForRepurchaseOfCommonStock,PaymentsForRestructuring,PaymentsOfDividendsCommonStock,PaymentsOfStockIssuanceCosts,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,PaymentsToAcquireMarketableSecurities,PaymentsToAcquirePropertyPlantAndEquipment,PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent,PreferredStockDividendsIncomeStatementImpact,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PreferredStockValue,ProceedsFromDivestitureOfBusinesses,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions,ProceedsFromRepaymentsOfNotesPayable,ProceedsFromRoyaltiesReceived,ProceedsFromSaleAndMaturityOfMarketableSecurities,ProceedsFromSaleOfIntangibleAssets,ProceedsFromSaleOfPropertyPlantAndEquipment,ProceedsFromStockOptionsExercised,ProceedsFromStockPlans,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ProvisionForDoubtfulAccounts,RepaymentsOfNotesPayable,ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned,ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross,ResearchAndDevelopmentExpense,RestrictedCashAndCashEquivalents,RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated,RestructuringCharges,RestructuringReserve,RestructuringReserveAccrualAdjustment,RestructuringReserveCurrent,RestructuringReserveNoncurrent,RestructuringReserveSettledWithCash,RetainageDeposit,RetainedEarningsAccumulatedDeficit,RevenueRecognitionMilestoneMethodRevenueRecognized,Revenues,RoyaltyIncomeNonoperating,RoyaltyRevenue,SalesRevenueNet,SecurityDeposit,SeveranceCosts,SeveranceCosts1,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares,SharePrice,ShortTermInvestments,StockholdersEquity,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueEmployeeStockPurchasePlan,StockIssuedDuringPeriodValueShareBasedCompensation,StockIssuedDuringPeriodValueShareBasedCompensationGross,StockIssuedDuringPeriodValueStockOptionsExercised,StockOptionPlanExpense,StockRepurchasedAndRetiredDuringPeriodShares,StockRepurchasedAndRetiredDuringPeriodValue,StockRepurchaseProgramAuthorizedAmount,StockRepurchaseProgramAuthorizedAmount1,TangibleAssetImpairmentCharges,TaxCreditCarryforwardAmount,UnamortizedDebtIssuanceExpense,ValuationAllowanceAmount,ValuationAllowanceDeferredTaxAssetChangeInAmount,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesOutstandingBasic,WriteOffOfDeferredDebtIssuanceCost,StockIssuedDuringPeriodValueNewIssues
2008-12-31,2009-03-09,10-K,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,79711000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41661000.0,,,,,,,,,,,,,,,,,,,,,
2009-12-31,2010-03-12,10-K,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,,,,,,,,,,,,,,1364000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,50440000.0,-29271000.0,,,,-6327000.0,66605000.0,,,,,,,,,,4660000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6915000.0,,,,,,,,,,,,,,0.02,,,,,,,,,,,,,,,,,,,-4848000.0,0.0,,-57202000.0,,-59287000.0,-1.26,,,57885000.0,1.28,,,-2085000.0,,,,,,,,,,,,,,,,-361000.0,,,,,-1709000.0,-2785000.0,,,,11514000.0,,,,,4312000.0,,,,,,,,,,,-11000.0,,,,-18121000.0,,-26147000.0,-19820000.0,14997000.0,-51608000.0,683000.0,,,,,,108501000.0,-57093000.0,,,,,,,,,,,,,,,,,,730000.0,,,,,,3247000.0,37582000.0,,,-1086000.0,,5008000.0,,,0.0,,2015000.0,,,,1107000.0,109791000.0,1987000.0,,,,,,,,0.0,,852000.0,-15602000.0,,91958000.0,,0.0,,-249000.0,,,,,,0.0,24587000.0,45639000.0,,,693000.0,,,,,,,,,,,51408000.0,51408000.0,,,,7861000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,53283000.0,,,795000.0,8126000.0,,56000.0,,,-2015000.0,,,232000.0,,,,,,,,,
2010-03-31,2010-05-10,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9700000.0,,,,,,,,,,,,,,6100000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2010-06-30,2010-08-09,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,308000000.0,303000000.0,5000000.0,,399180000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,176400000.0,,,,,,,,,,,-0.09,,-0.09,,,,,,,,,,,,,,,,,,,,,-5571000.0,,-5776000.0,,-0.09,-0.09,-51000.0,,0.0,0.0,-205000.0,,,,,,,,,,,,,,,,,,,,,,,,,,1480000.0,,,,,811000.0,,,,,,,,,,,,,,,,,,,,,-5622000.0,,,,,,18793000.0,-5076000.0,,,,,,,,,,,,,,,,,,,,,,,,,5772000.0,,,,,-31000.0,,,527000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2602000.0,1759000.0,10131000.0,,,900000.0,,,,,,,,,,,10588000.0,13717000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60849000.0,,60849000.0,,
2010-09-30,2010-11-04,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,408594000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.14,,-0.14,,,,,,,,,,,,,,,,,,,896000.0,,-8354000.0,,-8485000.0,,-0.14,-0.14,0.0,,0.0,0.0,-131000.0,,,,,,,,,,,,,,,,,,,,,,,,,,1479000.0,,,,,1110000.0,,,,,,,,,,,,,,,,,,,,,-8354000.0,,,,,,20624000.0,-7394000.0,,,,,,,,,,,,400000.0,,,,,,,,,,,,,4682000.0,,,,,174000.0,,,111000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2217000.0,1197000.0,14206000.0,,,453000.0,,,,,,,,,,,10902000.0,13230000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60840000.0,,60840000.0,,
2010-12-31,2011-03-16,10-K,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,4192000.0,,,14195000.0,,,,,,38286000.0,914000.0,454657000.0,,576000.0,18800000.0,,,,488857000.0,434616000.0,,,,,,,31170000.0,,,,,,,,,,,,,,,397530000.0,347090000.0,,,,-105000.0,436000.0,,,0.0,,0.01,170000000.0,58817561.0,58817561.0,588000.0,175829000.0,-140000.0,,-337000.0,200000.0,,,0.04,,,,,,,,,,,,,,,,,,,,,,800000.0,800000.0,,,700000.0,,,,5800000.0,5811000.0,,,,,0.0,,,,,,,,,3.03,,,,,,,,,,,,,,,,,,,0.0,896000.0,0.0,-2800000.0,-3137000.0,-2800000.0,-0.05,,,180043000.0,3.08,,,-337000.0,-337000.0,100000.0,,,588000.0,-140000.0,,-1098000.0,2348000.0,,,826000.0,-199000.0,2662000.0,,2801000.0,,,,,4299000.0,-644000.0,,,,6315000.0,,,,,3465000.0,2600000.0,,157000000.0,488857000.0,18387000.0,,134499000.0,,,31170000.0,589000.0,31394000.0,900000.0,,-19506000.0,,343981000.0,344086000.0,22615000.0,22179000.0,177243000.0,,,,,,98440000.0,-575000.0,,,,,,,,,,,300000.0,,,,5916000.0,1273000.0,-742000.0,-742000.0,-589000.0,-1414000.0,,,-979000.0,-672000.0,25439000.0,4114000.0,,0.0,,1184000.0,,1316000.0,2752000.0,-896000.0,48170000.0,,,,3443000.0,2834000.0,1967000.0,,,0.01,3000000.0,0.0,0.0,0.0,262581000.0,,32260000.0,0.0,,86306000.0,,0.0,31800000.0,-153000.0,,,21574000.0,,,9273000.0,7135000.0,49883000.0,,,14026000.0,,,,,,,-124302000.0,27000000.0,,,44940000.0,97865000.0,,15710000.0,,6869000.0,,,,,,,,,,0.42,0.026,,,,11800000.0,,,,,,,4.42,,,,,,,,,,,,,,31170000.0,331857000.0,,114751000.0,509000.0,3904000.0,3904000.0,31751000.0,,,48170000.0,,,1082000.0,,,,,,58466.0,,,
2011-03-31,2011-05-06,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,,,,,,,,,,,,,,135000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,369938000.0,-27592000.0,,,,,,,,,,,,,,,284000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1374000.0,,,,,,,,,,,,,0.01,,0.01,,,,,,,,,,,,,,,,,,0.0,,,431000.0,431000.0,,,0.01,0.01,,,,,0.0,,,,,,,,,,,,,,,,,,,,2474000.0,,,,,,1480000.0,,,,,459000.0,,,,,,,,,,,22000.0,,,,-41744000.0,,13106000.0,,1046000.0,,431000.0,,,,,,16698000.0,1324000.0,,,,,,,,,,,,,,,,,,,,-147000.0,-22000.0,,,-125000.0,5086000.0,,,-393000.0,,128000.0,,,166000.0,,41401000.0,,,,684000.0,344000.0,88000.0,,,,,,,,5000000.0,,216000.0,0.0,,13538000.0,,,,125000.0,,,,,,1094000.0,647000.0,10548000.0,,,400000.0,,,,,,,,5000000.0,,,11762000.0,18022000.0,,,,1209000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,58736000.0,,58002000.0,,
2011-06-30,2011-08-05,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,1430000.0,,,11050000.0,,,,,,39983000.0,556000.0,365331000.0,,,,,,,386699000.0,363139000.0,,,,,,,,,,,,,,,,,,,,,,317867000.0,,,,,,,,,,,0.01,170000000.0,50631943.0,50631943.0,506000.0,-7279000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.13,,-0.13,,,,,,,5000.0,,,,,,,,,,,,,,-7068000.0,-7063000.0,-7063000.0,,-0.13,-0.13,0.0,,0.0,0.0,5000.0,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,1479000.0,0.0,,,,386000.0,,,151245000.0,386699000.0,12480000.0,,134499000.0,,,,,3316000.0,,,,,,,,,-7068000.0,-7068000.0,-7068000.0,,,,15600000.0,-6001000.0,,,,,,,,,,,,,,,4189000.0,759000.0,,,,-211000.0,-58000.0,,,-153000.0,4627000.0,4266000.0,,,,31000.0,,,196000.0,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,19485000.0,,,231000.0,184000.0,10061000.0,,,674000.0,,,,,,,-130939000.0,,,,9172000.0,9599000.0,,700000.0,700000.0,700000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41083000.0,235454000.0,,,,,,,,,,,,,,,,,53054000.0,,53054000.0,,
2011-09-30,2011-11-04,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,757000.0,,,14009000.0,,,,,,41431000.0,94000.0,341207000.0,,,,,,,354538000.0,333165000.0,,,,,,,25250000.0,,,,,,,,,,,,,,,304995000.0,,,,,,,,,,,0.01,170000000.0,48273397.0,48273397.0,483000.0,-9567000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.19,,-0.19,,,,,,,200000.0,,,,,,,,,,,,0.0,,-9105000.0,-8905000.0,-8905000.0,,-0.19,-0.19,0.0,,0.0,0.0,200000.0,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,1480000.0,0.0,,,,407000.0,,,152798000.0,354538000.0,14766000.0,,134499000.0,,,,,2743000.0,,,,,,,,,-9105000.0,-9105000.0,-9105000.0,,,,18203000.0,-7763000.0,,,,,,,,,,,,,,,2920000.0,565000.0,,,,-462000.0,-139000.0,,,-323000.0,4102000.0,3533000.0,,,,-69000.0,,,179000.0,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,18065000.0,,,54000.0,47000.0,10436000.0,,,700000.0,,,,,,,-140044000.0,,,,10207000.0,10440000.0,,2900000.0,2900000.0,700000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,201740000.0,,,,,,,,,,,,,,,,,48729000.0,,48729000.0,,
2011-12-31,2012-03-12,10-K,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,1572000.0,,2634000.0,13692000.0,658000.0,0.0,,,,40573000.0,3000.0,341760000.0,,567000.0,17400000.0,,,,343209000.0,165261000.0,,,,,218967000.0,,,,,,,218967000.0,200000.0,,,212000.0,212000.0,,,,,104324000.0,-293206000.0,,,,0.0,0.0,,,0.0,2.0,0.01,170000000.0,48292702.0,48292702.0,483000.0,-21674000.0,0.0,,205000.0,,,,,,2533000.0,2500000.0,,,,3165000.0,107809000.0,7512000.0,0.0,0.0,107800000.0,,444000.0,61213000.0,3153000.0,1530000.0,27647000.0,,2554000.0,107365000.0,444000.0,800000.0,0.0,1000.0,4000000.0,,,,5300000.0,5336000.0,,,,,0.0,,,,,,,,-0.5,-0.4,-0.5,,,,,,,,,,,,,,,0.0,,,0.0,0.0,0.0,-25784000.0,-20558000.0,-20763000.0,-0.4,-0.1,-0.1,0.0,0.0,,,205000.0,205000.0,200000.0,,,8340000.0,0.0,,-7195000.0,205000.0,,,174000.0,20000.0,1339000.0,,-2620000.0,,,,,-3250000.0,-3506000.0,,,,5929000.0,,,,432000.0,1735000.0,1600000.0,25532000.0,146028000.0,343209000.0,15264000.0,,129499000.0,30052000.0,,58188000.0,240000.0,160779000.0,,98100000.0,-121242000.0,-121242000.0,-159239000.0,-159239000.0,-12725000.0,-12725000.0,-25784000.0,,,,0.0,,64527000.0,-16455000.0,,,,,,,,,,,600000.0,,,979000.0,2749000.0,367000.0,0.0,,-240000.0,-911000.0,,,-671000.0,-911000.0,17281000.0,1265000.0,2500000.0,-61000.0,,91000.0,,1103000.0,718000.0,0.0,120793000.0,,0.0,,1155000.0,263061000.0,630000.0,3843000.0,,0.01,3000000.0,0.0,0.0,0.0,0.0,,5873000.0,-5000000.0,,104448000.0,,4000.0,5500000.0,-167000.0,,57375000.0,16802000.0,,5000000.0,1431000.0,926000.0,40180000.0,98100000.0,,7425000.0,4484000.0,,,,,,-145065000.0,,,,40923000.0,58083000.0,,6022000.0,6022000.0,3139000.0,,,,,674000.0,10.14,,,,0.42,0.015,,,,1900000.0,,,,,,,3.29,,3121000.0,10.88,,,,,,,,,,,,197181000.0,,,420000.0,1918000.0,1918000.0,5453000.0,700000.0,,120793000.0,,,0.0,,700000.0,107400000.0,,51910000.0,51910.0,51910000.0,30000.0,
2012-03-31,2012-05-02,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,1898000.0,,,11072000.0,,,,,,41869000.0,575000.0,342224000.0,,147000.0,,,,,336946000.0,127150000.0,,,,,,,,,,,,,35000.0,,,,,,,,,46214000.0,-58110000.0,,,,,,,,,,0.01,170000000.0,48292702.0,48292702.0,483000.0,-499000.0,,,,,,,,3750000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1296000.0,,,,,,,,,,,,,-0.02,,-0.02,,,,,,,,,,,,,,,0.0,,113000.0,113000.0,,,-1071000.0,-1071000.0,,,-0.02,-0.02,,,,,0.0,,0.0,,,,,,,,,,,,,,,,,,-2236000.0,,,,0.0,0.0,1417000.0,0.0,25000.0,,,478000.0,,,139800000.0,336946000.0,12970000.0,,125749000.0,,,78480000.0,35000.0,194038000.0,,,-3848000.0,,-53766000.0,,-496000.0,,-1071000.0,-1071000.0,-1071000.0,,,,10637000.0,-36000.0,,,,,,,,,,,,,,,2456000.0,252000.0,,,,572000.0,35000.0,,,537000.0,3675000.0,1081000.0,,-752000.0,,-96000.0,,,177000.0,,0.0,,,,0.0,94755000.0,0.0,,,0.01,3000000.0,0.0,0.0,0.0,,,0.0,-3863000.0,,40989000.0,,,,15000.0,,,15506000.0,,,103000.0,85000.0,6914000.0,,,-37000.0,,,,,,,-146136000.0,,,,10321000.0,10601000.0,,,,468000.0,,,,,,,,,,,,17339.0,,,,,,,,,,,,,,,,,,,,,,,,,197146000.0,,,,,,,,,,,,,,,,,48293000.0,,48293000.0,20000.0,
2012-06-30,2012-08-03,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,616000.0,,,8425000.0,,,,,,43136000.0,502000.0,337407000.0,,,,,,,317049000.0,132203000.0,,,,,239653000.0,,,238301000.0,68262000.0,68306000.0,238756000.0,240155000.0,16000.0,,,-104000.0,606000.0,,,,,59441000.0,,,,,,,,,0.0,,0.01,170000000.0,47545103.0,47545103.0,475000.0,-802000.0,,,,,,,,9900000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.02,,-0.02,,,,,3400000.0,300000.0,33000.0,,,,,,,,,,99000.0,,,,-729000.0,-696000.0,,,-0.02,-0.02,,,,,33000.0,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,1364000.0,0.0,,,400000.0,523000.0,,,125530000.0,317049000.0,124890000.0,,0.0,,240155000.0,69705000.0,,170450000.0,,42900000.0,,,,,,,-729000.0,-729000.0,-729000.0,115849000.0,115849000.0,117974000.0,9989000.0,242000.0,,,,,,,,,,,,,,,3057000.0,156000.0,,,,-73000.0,-16000.0,16000.0,,-57000.0,4358000.0,640000.0,1400000.0,,,-97000.0,,,427000.0,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,14240000.0,,,33000.0,28000.0,5673000.0,,,-70000.0,2101000.0,,,,,,-146865000.0,,,,9771000.0,10231000.0,,,,500000.0,,,,,574000.0,,,,,,,,2789000.0,,,,,,,,,,,2984000.0,,,2951000.0,,,,,,,,,,191519000.0,,,,,,,,788300.0,5300000.0,,,,,,,,48176000.0,,48176000.0,42000.0,
2012-09-30,2012-11-09,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,1058000.0,,,7394000.0,,,,,,43992000.0,113000.0,321840000.0,,,,,,,304468000.0,280674000.0,,,,,147678000.0,,,147678000.0,137396000.0,137492000.0,147791000.0,147791000.0,1000000.0,,,-29000.0,142000.0,,,,,140946000.0,,,,,,,,,0.0,,0.01,170000000.0,45207688.0,45207688.0,452000.0,3786000.0,,,,,,,,13650000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.09,,0.08,,,,,3500000.0,300000.0,,,,,,,,,,,,,,,4175000.0,4175000.0,,,0.09,0.08,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,12131.0,45.0,1274000.0,753000.0,,,1500000.0,1386000.0,,,124753000.0,304468000.0,124301000.0,,0.0,,147791000.0,137492000.0,,10299000.0,,115200000.0,,,,,,,4175000.0,4928000.0,4175000.0,115849000.0,115849000.0,118166000.0,7060000.0,4061000.0,,,,,,,,,,,,,,,2236000.0,172000.0,,,,-389000.0,-979000.0,979000.0,,590000.0,3209000.0,452000.0,,,,2000.0,,,202000.0,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,13323000.0,,,0.0,10000.0,3954000.0,,,-113000.0,1225000.0,,,,,,-142690000.0,,,,10919000.0,11121000.0,,,,600000.0,,,,,619000.0,,,,,,,17339.0,2712000.0,,,,,,,,,,,2917000.0,,,2881000.0,,,,,,,,,,179715000.0,,,,,,,,,,,,,,,,,58563.0,,46387.0,,
2012-12-31,2013-03-18,10-K,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,776000.0,,1442000.0,5688000.0,360000.0,324000.0,0.0,,,25783000.0,83000.0,224796000.0,41000.0,541000.0,17100000.0,,,,199781000.0,198643000.0,0.0,,,119391000.0,119308000.0,38100000.0,,119308000.0,119308000.0,119391000.0,119391000.0,119391000.0,900000.0,94000.0,11000.0,11000.0,94000.0,,,,,77348000.0,-26976000.0,,,,0.0,0.0,,25530000.0,2.0,,0.01,170000000.0,43674170.0,43674170.0,437000.0,-2703000.0,30000.0,,-4135000.0,,147.8211,6.76,0.04,,0.0,,,,,3165000.0,102097000.0,6613000.0,613000.0,0.0,102100000.0,,34000.0,56329000.0,1167000.0,1560000.0,25379000.0,0.0,3007000.0,102063000.0,34000.0,,0.0,-34000.0,100000.0,0.06,0.5,,4300000.0,4263000.0,,,,,-87348000.0,,87348000.0,,,,,,-0.16999999999999998,-0.06,-0.16999999999999998,,0.35,,3100000.0,,,,,,,,,,,0.0,,,,0.0,11263000.0,-7941000.0,-6918000.0,-2783000.0,-0.06,-0.11,-0.11,0.0,0.0,,,-4135000.0,-4135000.0,6000.0,,,865000.0,0.0,,-2421000.0,119000.0,,,-26000.0,-2672000.0,0.0,,-796000.0,,,,,-9176000.0,-671000.0,,,,5330000.0,,,,386000.0,2578000.0,1200000.0,1095000.0,122313000.0,199781000.0,122313000.0,,115849000.0,24082000.0,119391000.0,119391000.0,957000.0,0.0,,,-132985000.0,-132985000.0,97557000.0,97557000.0,8452000.0,8452000.0,-7941000.0,,,115849000.0,115849000.0,117079000.0,46566000.0,-3966000.0,,6376000.0,753000.0,,,703000.0,703000.0,703000.0,3514000.0,400000.0,700000.0,,144100000.0,998000.0,1904000.0,0.0,0.0,,-957000.0,80000.0,,,1037000.0,,14475000.0,0.0,,-265000.0,,-200000.0,,62000.0,970000.0,0.0,31744000.0,3468000.0,87348000.0,,137000.0,208267000.0,23000.0,777000.0,,0.01,3000000.0,0.0,0.0,0.0,0.0,,130000.0,-13862000.0,,305838000.0,,9000.0,0.0,-24000.0,,26921000.0,1138000.0,,13862000.0,126000.0,113000.0,20892000.0,50500000.0,,-177000.0,777000.0,13000.0,,,,,-147848000.0,,,,41504000.0,53247000.0,,900000.0,-239000.0,2119000.0,220000.0,9.69,263000.0,6.9,868000.0,9.06,99000.0,900000.0,9.25,0.4,0.008,,2019000.0,9.49,0.0,920000.0,,,167000.0,,258000.0,2.08,61000.0,2292000.0,6.99,56000.0,2240000.0,9.02,0.0,14.68,7.08,4.72,42000.0,,,,77468000.0,0.0,,130000.0,,1952000.0,,400000.0,4713000.0,31744000.0,,,0.0,,200000.0,102100000.0,,46735000.0,46735.0,46735000.0,62000.0,
2013-03-31,2013-05-10,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,673000.0,,,6320000.0,,,,,,,39000.0,224436000.0,,116000.0,,,,,202298000.0,201257000.0,,,,,77528000.0,34100000.0,,77528000.0,77528000.0,77567000.0,77567000.0,77567000.0,300000.0,,,16000.0,55000.0,,,,,121742000.0,44394000.0,,,,,,,,,,0.01,170000000.0,43715451.0,43715451.0,437000.0,2148000.0,,,,,,6.76,0.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,80000.0,,,,,,,,,,,,,0.05,,0.05,,,,,1500000.0,300000.0,,,,,,,,,219000.0,,,0.0,,,,2523000.0,,,,,,,,,133000.0,,0.0,,,,,,,,,,,,,,,,,,-388000.0,,,,17125000.0,300000.0,1274000.0,754000.0,0.0,,1500000.0,427000.0,,,122842000.0,202298000.0,122842000.0,,,,77567000.0,77566000.0,281000.0,,,,-120000.0,-120000.0,41761000.0,41761000.0,2753000.0,2753000.0,2390000.0,3144000.0,2390000.0,115849000.0,115849000.0,116212000.0,7033000.0,3150000.0,,,,,,,,,,,,,,,1949000.0,,,,,-242000.0,-281000.0,281000.0,,39000.0,2949000.0,,,,,220000.0,,,619000.0,,,1600000.0,,,106000.0,0.0,-235000.0,,,0.01,3000000.0,0.0,0.0,0.0,,,,0.0,,41526000.0,700000.0,235000.0,,-14000.0,,,1041000.0,,,0.0,0.0,1579000.0,,,2500000.0,900000.0,2534000.0,,,,,-145456000.0,,,,9564000.0,10183000.0,,,,-257000.0,261000.0,,0.0,,542000.0,,65000.0,,,,,,2090000.0,,,,78000.0,,,,156000.0,1.24,,2370000.0,,,2326000.0,,,,,4.54,,,,,79456000.0,0.0,,,,,,,,,,,,,77000.0,,,61118000.0,,43693000.0,,
2013-06-30,2013-08-06,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,596000.0,,,2004000.0,,,,,,,-3000.0,154354000.0,,,,,,,16649000.0,15747000.0,,,,3001000.0,3004000.0,3000000.0,,3004000.0,3004000.0,3001000.0,3001000.0,,39000.0,,,,,,,,,11456000.0,,,,,,,,,1.6,1.6,0.01,170000000.0,43731646.0,43731646.0,437000.0,4677000.0,,,,,,,0.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.11,,0.09,,,,,1100000.0,400000.0,,,,,,,,,,,,,,,,4799000.0,,,,,,,,,80000.0,,,,,,,,,,,,,,,,,,132000.0,,,,,,11417000.0,126000.0,850000.0,457000.0,,,,103000.0,,,2600000.0,16649000.0,2600000.0,,,,3001000.0,3001000.0,,,,,,,,,,,4719000.0,5176000.0,4719000.0,,0.0,,3156000.0,4900000.0,,,,,,,,,,,,,,,1290000.0,,,,,-42000.0,,39000.0,,-3000.0,2398000.0,,,,,646000.0,,,12000.0,,,501000.0,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,902000.0,,,0.0,0.0,294000.0,,,596000.0,189000.0,596000.0,,,,,-140739000.0,,,,8044000.0,8056000.0,,,,,,,,,860000.0,,,,,,,,2086000.0,,,,,,,,,,,2356000.0,,,2313000.0,,,,,,,,,,14049000.0,,,,,,,,,,,,,,,,,55272000.0,,43729000.0,,
2013-09-30,2013-11-12,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,201000.0,,,2286000.0,,,596000.0,,,,0.0,154515000.0,,,,30000.0,30000.0,30000.0,22862000.0,22862000.0,529000.0,,,,,,,,,,,,39000.0,,,,,,,,,21691000.0,,,,,,,,,0.0,,0.01,170000000.0,44068299.0,44068299.0,441000.0,5566000.0,186000.0,55000.0,,,,,0.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.13,,0.13,,,,,800000.0,200000.0,,,,,,,,,,,,,,,,5321000.0,,,,,,,,,-241000.0,,,,,,,,,,,,,,,,,,,,,,,,0.0,216000.0,0.0,0.0,,,,4000.0,,,3083000.0,22862000.0,2487000.0,,,,,0.0,,,,,,,,,,,5562000.0,5562000.0,5562000.0,,0.0,,3706000.0,5122000.0,,3052000.0,65000.0,2489000.0,394000.0,374000.0,374000.0,373000.0,1472000.0,,,,,,642000.0,,,,,4000.0,,0.0,,4000.0,2259000.0,,,,,195000.0,,,0.0,,,129000.0,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,0.0,,,0.0,0.0,653000.0,,4.0,794000.0,854000.0,794000.0,503000.0,291000.0,,,-135177000.0,,,,8828000.0,8828000.0,,,,300000.0,,,,,421000.0,,,,,,,,2034000.0,,,,,,,,,,,2289000.0,,,2250000.0,,,,,,,,,,19779000.0,,,,,,,,,,,,,,,,,44137000.0,,43921000.0,,
2013-12-31,2014-03-14,10-K,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,93000.0,,85000.0,1215000.0,150000.0,239000.0,558000.0,,,,0.0,134512000.0,4000.0,193000.0,22000.0,,30000.0,,7121000.0,7121000.0,90000.0,90000.0,90000.0,,,,,119308000.0,119308000.0,119391000.0,119391000.0,,300000.0,,,,,,,,,6520000.0,-70828000.0,,,,,,,,2.5,0.45,0.01,170000000.0,44085870.0,44085870.0,441000.0,18067000.0,-30000.0,,-28000.0,,,,,,,,,,,3663000.0,94435000.0,0.0,0.0,0.0,94400000.0,,0.0,56198000.0,1537000.0,1530000.0,25379000.0,84000.0,2518000.0,94935000.0,0.0,,,0.0,56000.0,0.06,,0.5,200000.0,232000.0,,,,,,,89808000.0,,0.0,,,,0.53,,0.5,,0.35,,,,,,2312000.0,1085000.0,420000.0,193000.0,356000.0,258000.0,,1554000.0,,,,,0.0,,18122000.0,,,,,,,,,-28000.0,,186000.0,,,-6526000.0,0.0,,6313000.0,183000.0,,,0.0,2000.0,0.0,,-683000.0,,,,,-3877000.0,-1334000.0,,,,2124000.0,,,,0.0,534000.0,,,1866000.0,7121000.0,1308000.0,,,,,0.0,320000.0,,,,,-205961000.0,,121128000.0,,14005000.0,23629000.0,,,,0.0,,16334000.0,18159000.0,,4920000.0,703000.0,,,774000.0,742000.0,703000.0,1998000.0,,87000.0,,144000000.0,249000.0,511000.0,,,,-320000.0,-83000.0,,,237000.0,237000.0,8843000.0,,,0.0,,1553000.0,,775000.0,647000.0,,0.0,4648000.0,89808000.0,,283000.0,0.0,0.0,332000.0,,0.01,3000000.0,0.0,0.0,0.0,,,12000.0,,,118894000.0,,2234000.0,0.0,,,,0.0,,115849000.0,0.0,0.0,2715000.0,,,4776000.0,905000.0,4943000.0,,,,,-129698000.0,,,,33846000.0,41919000.0,,,4001000.0,-205000.0,655000.0,8.77,0.0,0.0,166000.0,8.13,534000.0,2000000.0,9.47,0.343,0.008,,2051000.0,7.06,0.0,102000.0,,,221000.0,,156000.0,1.24,0.0,2125000.0,6.9,0.0,2125000.0,6.9,0.0,10.86,3.03,2.94,0.0,,,,5255000.0,0.0,,12000.0,,-484000.0,,100000.0,,,,,,,,,,51045000.0,,43782000.0,,
2014-03-31,2014-05-09,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,188000.0,,,744000.0,,,512000.0,,,,,134506000.0,,0.0,,30000.0,,,15217000.0,,55000.0,,,,,,,,,,,,,,,,,,,,,14863000.0,8343000.0,,,,,,,,,,0.01,170000000.0,44093827.0,44093827.0,441000.0,8521000.0,55000.0,,,,,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,,,,0.19,,0.19,,,,,,,,,,,,,,,109000.0,,,,,,,8576000.0,,,,,,,,,55000.0,,,,,,,,,,,,,,,,,,,,208000.0,,,208000.0,0.0,161000.0,0.0,0.0,,,,109000.0,,,1444000.0,15217000.0,932000.0,,,,,,0.0,,,,,-7000.0,,146000.0,,8204000.0,8521000.0,8521000.0,8521000.0,,,,508000.0,8467000.0,,,,,,,,,,,,,,,299000.0,,,,,,,0.0,,0.0,508000.0,,,,,109000.0,,,31000.0,,,400000.0,0.0,,7000.0,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,0.0,,146000.0,,0.0,,,,,,,,0.0,,,0.0,686000.0,0.0,,,,,-121174000.0,,,,8944000.0,8975000.0,,,,0.0,0.0,,0.0,,152000.0,,-14000.0,,,,,,1820000.0,,,,-237000.0,,,,0.0,,,1888000.0,,,1888000.0,,,,,,,,,,13773000.0,0.0,,,,,,,,,,,,,,,,44253000.0,,44092000.0,,
2014-06-30,2014-08-08,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,257000.0,,,539000.0,,,467000.0,,,,,134490000.0,,,,,,,21901000.0,,,,0.0,,,,,,,,,,,,,,,,,,,21477000.0,,,,,,,,,0.0,,0.01,170000000.0,44125410.0,44125410.0,441000.0,6882000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.16,,0.16,,,,,,,,,,,,,,,,,,,,,,6882000.0,,,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,0.0,141000.0,0.0,0.0,,,,-48000.0,,,1263000.0,21901000.0,796000.0,,,,,,,,,,,,,,,,6882000.0,6882000.0,6882000.0,,,,836000.0,6930000.0,,,,,,,,,,,,,,,424000.0,,,,,0.0,,0.0,,0.0,836000.0,,,,,-48000.0,,,31000.0,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,0.0,,,0.0,505000.0,,,,,,-114293000.0,,,,7735000.0,7766000.0,,,,,,,,,104000.0,,,,,,,,1787000.0,,,,,,,,,,,1854000.0,,,1854000.0,,,,,,,,,,20638000.0,,,,,,,,,,,,,,,,,44253000.0,,44112000.0,,
2014-09-30,2014-11-06,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,151000.0,,,529000.0,,,422000.0,,,,,134482000.0,,,,,30000.0,,29322000.0,,,,0.0,,,,,,,,,,,,,,,,,,,28993000.0,,,,,,,,,0.0,,0.01,170000000.0,44142340.0,44142340.0,441000.0,7592000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.17,,0.17,,,,,,,,,,,,,,0.0,,,,,,,,7593000.0,,,,,,,,,1000.0,,,,,,,,,,,,,,,,,,,,,,,,0.0,108000.0,0.0,0.0,,,,0.0,,,1102000.0,29322000.0,680000.0,,,,,,,,,,,,,,,,7592000.0,7592000.0,7592000.0,,,,571000.0,7593000.0,,,,,,,,,,,,,,,329000.0,,,,,0.0,,0.0,,0.0,571000.0,,,,,0.0,,,31000.0,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,0.0,,,0.0,425000.0,,,,,,-106703000.0,,,,8133000.0,8164000.0,,,,,,,,,77000.0,,,,,,,,1737000.0,,,,,,,,,,,1804000.0,,,1804000.0,,,,,,,,,,28220000.0,,,,,,,,,,,,,,,,,44239000.0,,44131000.0,,
2014-12-31,2015-03-05,10-K,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,181000.0,,5000.0,458000.0,88000.0,171000.0,381000.0,,,,,130065000.0,0.0,0.0,0.0,,30000.0,,35040000.0,35040000.0,,,0.0,,,,,,,,,,,,,,,,,,34562000.0,34562000.0,28042000.0,,,,,,,,0.0,,0.01,170000000.0,44174456.0,44174456.0,441000.0,28795000.0,0.0,,56000.0,,,,,,,,,0.0,,3647000.0,76894000.0,,0.0,0.0,76900000.0,0.0,,45221000.0,1109000.0,1530000.0,19911000.0,43000.0,2518000.0,76894000.0,,,,,0.0,0.06,,0.5,,0.0,,,,,,,4417000.0,,4417000.0,,,,0.65,,0.65,,0.35,,,,,,,,,,,,0.0,61000.0,,,,,0.0,,28851000.0,,,,,,,,,56000.0,,55500.0,,,-10097000.0,,,10097000.0,0.0,,,56000.0,0.0,,,88000.0,,,,,-934000.0,-33000.0,,,120000.0,0.0,,,,,61000.0,,,5437000.0,35040000.0,5056000.0,,,,,,0.0,,,,,-4447000.0,,151000.0,,32338000.0,28795000.0,,28795000.0,,,,2383000.0,28790000.0,,,,,,,,,,,,,,194000.0,478000.0,,,,0.0,0.0,,,,0.0,2383000.0,,,,,61000.0,,,135000.0,,,555000.0,4417000.0,,30000.0,,,0.0,,0.01,3000000.0,0.0,0.0,0.0,,,0.0,,,0.0,,151000.0,,,,,,,0.0,,,0.0,,,0.0,268000.0,0.0,,,,,-100903000.0,,,,31038000.0,31173000.0,,,,0.0,0.0,0.0,0.0,0.0,45000.0,6.33,121000.0,-200000.0,8.77,,,,470000.0,4.51,,,-1606000.0,7.64,,,0.0,0.0,0.0,519000.0,4.08,0.0,519000.0,4.08,0.0,,,0.0,0.0,,,,29603000.0,0.0,,,,30000.0,,0.0,,,,,,,,,0.0,44245000.0,,44125000.0,,
2015-03-31,2015-05-13,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,241000.0,,,468000.0,,,351000.0,,,,,130059000.0,,,,,,,37830000.0,35287000.0,,,,,,,,,,,,,,,,,,,,,34804000.0,34804000.0,242000.0,,,,,,,,,,0.01,170000000.0,44182414.0,44182414.0,441000.0,,2495000.0,,,,,,,,,,,-2498000.0,,,,,,,,2543000.0,,,,,,,,2500000.0,,,,,,,,,,,,,,,,,,,0.0,,,,0.16,,0.16,,,,,,,,,,,,,,,0.0,,,,,,,4678000.0,,,,,,,,,-2495000.0,,0.0,,,,,,,,,,,,,,,,,,,,,10000.0,,46000.0,,,,0.0,,0.0,,,1060000.0,37830000.0,709000.0,,,,,,,,,,,-4423000.0,,0.0,,4665000.0,7173000.0,,7173000.0,,,,583000.0,4678000.0,,,,,,,,,,,,,,,483000.0,,,,,,,,,,583000.0,,,,,0.0,,,56000.0,,,,4417000.0,,6000.0,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,-93730000.0,,,,5205000.0,5261000.0,,,,,0.0,,0.0,,32000.0,,14000.0,,,,,,441000.0,,,,35000.0,,,,0.0,,,484000.0,,,484000.0,,,,,,,,,,36770000.0,0.0,,,,,,,,,,,,,,,,44227000.0,,44181000.0,,
2015-06-30,2015-08-07,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,48000.0,,,367000.0,,,322000.0,,,,,107968000.0,,,,,,,41288000.0,39606000.0,,,,,,,,,,,,,,,,,,,,,38993000.0,38993000.0,,,,,,,,,,,0.01,170000000.0,44182414.0,44182414.0,441000.0,,,,,,,,,,,,,,,,,,,,,1682000.0,,,,,,,,1780000.0,,,,,,,,,,,,,,,,,,0.5,22091000.0,22100000.0,,,0.09,,0.09,,,,,,,,,,,,,,,,,,,,,,4676000.0,,,,,,,,,894000.0,,,,,,,,,,,,,,,,,,,,,,,,,33000.0,,,,,,0.0,,,22828000.0,41288000.0,22506000.0,,,,,,,,,,,,,,,,3782000.0,,3782000.0,,,,516000.0,4676000.0,,,,,,,,,,,,,,,613000.0,,,,,,,,,,516000.0,,,,,0.0,,,95000.0,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-89949000.0,,,,5097000.0,5192000.0,,,,,,,,,32000.0,,,,,,,,389000.0,,,,,,,,,,,432000.0,,,432000.0,,,,,,,,,,18460000.0,,,,,,,,,,,,,,,,,44215000.0,,44182000.0,,
2015-09-30,2015-11-06,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,74000.0,,,135000.0,,,0.0,,,,,107968000.0,,,,,,,21407000.0,20559000.0,,,,,,,,,,,,,,,,,,,,,,20255000.0,,,,,,,,,,,0.01,170000000.0,44182414.0,44182414.0,441000.0,,,,,,,,,,,,,,,,,,,,,848000.0,,,,,,,,1780000.0,,,,,,,,,,,,,,,,,,,0.0,,,,-0.04,,-0.04,,,,,,,,,,,,,,-4552000.0,,,,,,,,-926000.0,,,,,,,,,888000.0,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,0.0,,,4761000.0,21407000.0,4761000.0,,,,,,,,,,,,,,,,-1814000.0,,-1814000.0,,,,4765000.0,-926000.0,,,,,,,,,,,,,,,304000.0,,,,,,,,,,213000.0,,,,,0.0,,,73000.0,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-91763000.0,,,,3766000.0,3839000.0,,,,,,,,,32000.0,,,,,,,,356000.0,,,,,,,,,,,398000.0,,,398000.0,,,,,,,,,,16646000.0,,,,,,,,,,,,,,,,,44182000.0,,44182000.0,,
2015-12-31,2016-03-21,10-K,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,90000.0,,15000.0,205000.0,0.0,0.0,0.0,,,,,96914000.0,0.0,,,30000.0,,,22890000.0,11779000.0,,,,,,,,,,,,,,,,,,,,,,11672000.0,-22890000.0,,,,,,,,0.85,,0.01,170000000.0,44214603.0,44214603.0,441000.0,,272000.0,,274000.0,,,,,,,,-11111000.0,-11111000.0,,482000.0,67679000.0,,,11111000.0,,11111000.0,,38487000.0,1819000.0,1803000.0,19911000.0,71000.0,2502000.0,56568000.0,,,,,,,,,,,,,,,,,33145000.0,,0.0,,,,0.49,,0.49,,0.35,,,,,,,,,,,,-4506000.0,0.0,,,,,,,10800000.0,,,,,,,,,-10837000.0,,183000000.0,,,-20326000.0,0.0,4500000.0,3780000.0,,0.0,,0.0,1000.0,,,-91000.0,,,,,-253000.0,-371000.0,,,23000.0,,,,,,0.0,,,4801000.0,22890000.0,4801000.0,,,,,,,,,,,-37568000.0,,0.0,,14678000.0,21637000.0,,21637000.0,,,,6656000.0,10800000.0,,,,,,,,,,,,,79000000.0,190000.0,107000.0,,,,,,,,,,2150000.0,,,,,,,,198000.0,,,0.0,37562000.0,,6000.0,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,0.0,,,,,,,,,,,,,,0.0,268000.0,,,,,-79266000.0,,,,17258000.0,17456000.0,,,52000.0,,0.0,0.0,0.0,0.0,0.0,0.0,45000.0,-100000.0,2.55,,,,323000.0,3.65,,,171000.0,3.13,,,0.0,0.0,0.0,348000.0,3.65,0.0,348000.0,3.65,0.0,,,0.0,0.0,,,,18089000.0,0.0,,,,6000.0,,0.0,16174578.0,153400000.0,,,,,,,11111000.0,44220000.0,,44197000.0,,
2016-03-31,2016-05-09,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,0.0,,,256000.0,,,,,,,,96914000.0,,,347919.0,,,,19862000.0,9779000.0,,,,,,,,,,,,,,,,,,,,,,9735000.0,-1937000.0,,,,,,,,,,0.01,170000000.0,44214603.0,44214603.0,441000.0,,,,,,,,,,,,,1028000.0,,,,,,,,10083000.0,,,,,,,,1028000.0,,,,,,,,,,,,,,,,,,,,,,,0.03,,0.03,,,,,,,,,,,,,,,,,,,,,,2545000.0,,,,,,,,,1028000.0,,97000.0,,,,,,,,,,,,,,,,,,,,,4482000.0,,0.0,,,,,,,,,,19862000.0,256000.0,,,,,,,,,,,0.0,,,,-1937000.0,1517000.0,,1517000.0,,,,721000.0,2545000.0,,,,,,,,,,,,,,,44000.0,,,,,,,,,,721000.0,,,,,,,,42000.0,,,,0.0,,0.0,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-77749000.0,,,,3224000.0,3266000.0,,,,,,,,,,,,,,,,,330000.0,,,,0.0,,,,0.0,,,348000.0,,,348000.0,,,,,,,,,,19606000.0,0.0,,,,,,,,,,,,,,,,44215000.0,,44215000.0,,
2016-06-30,2016-08-10,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,0.0,,,150000.0,,,,,,,,96916000.0,,,,,,,20791000.0,11509000.0,,,,,,,,,,,,,,,,,,,,,,11231000.0,,,,,,,,,,,0.01,170000000.0,43866611.0,43866611.0,439000.0,,,,,,,,,,,,,,,,,,,,,9282000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.02,0.02,0.02,,,,,,,,,,,,,,,,,,,,,,1836000.0,,,,,,,,,801000.0,,135000.0,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,20791000.0,150000.0,,,,,,,,,,,,,,,,1035000.0,,1035000.0,,,,436000.0,1836000.0,,,,,,,,,,,,,,,278000.0,,,,,,,,,,436000.0,,,,,,,,0.0,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-76714000.0,,,,2272000.0,2272000.0,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,,0.0,,,0.0,,,,,,,,,,20641000.0,,,,,,,,,,,,,,,,,44120.0,44120000.0,44120.0,,
2016-09-30,2016-11-10,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,0.0,,,163000.0,,,,,,,,96914000.0,,,,,,,21740000.0,13130000.0,,,,,,,,,,,,,,,,,,,,,,12896000.0,,,,,,,,,,,0.01,170000000.0,44214603.0,44214603.0,441000.0,,,,,,,,,,,,,,,,,,,,,8610000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.02,0.02,0.02,,,,,,,,,,,,,,0.0,,,,,,,,1610000.0,,,,,,,,,674000.0,,135000.0,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,21740000.0,163000.0,,,,,,,,,,,,,,,,936000.0,,936000.0,,,,376000.0,1610000.0,,,,,,,,,,,,,,,234000.0,,,,,,,,,,376000.0,,,,,,,,21000.0,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-75778000.0,,,,1965000.0,1986000.0,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,,0.0,,,0.0,,,,,,,,,,21577000.0,,,,,,,,,,,,,,,,,44214000.0,44214000.0,44214000.0,,
2016-12-31,2017-03-24,10-K,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,770000.0,,0.0,170000.0,140000.0,,,,770000.0,,,90281000.0,0.0,,,,,,11271000.0,7909000.0,,,,,,,,,,,,,,,,,,,,,,7639000.0,-4033000.0,,,,,,,,0.15,,0.01,170000000.0,44214603.0,44214603.0,442000.0,,19000.0,,21000.0,,,,,,,,7749000.0,7749000.0,,482000.0,59250000.0,,,3362000.0,,3362000.0,,40359000.0,0.0,1801000.0,16608000.0,0.0,0.0,55888000.0,,,,,,,,,,,,,,,,,6632000.0,,,,,,-0.03,,-0.03,0.417,0.35,,,,,,,,,,,,-54000.0,,,,,,,,6644000.0,,,,,,,,,7770000.0,,135000000.0,,0.0,680000.0,0.0,4500000.0,2325000.0,,2144000.0,0.0,,621000.0,,0.0,680000.0,,,0.0,,-35000.0,163000.0,,,0.0,,,,,,,,,,11271000.0,940000.0,,,,,,,,,,-6632000.0,-6632000.0,,,2599000.0,2599000.0,-1126000.0,,-1126000.0,,,,1733000.0,,,,,,,,,,,,42000.0,,84000000.0,30000.0,270000.0,,,,,,,,,,1679000.0,,,,,,0.0,,63000.0,,,,6632000.0,,0.0,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-80392000.0,,,,8314000.0,8377000.0,,,,,,,,,,,,,,,,,0.0,0.0,,,348000.0,3.65,,,0.0,0.0,0.0,219000.0,2.66,0.0,0.0,0.0,0.0,,,0.0,0.0,,,,10331000.0,0.0,,,,,,0.0,,,,,,,,,,44215000.0,,44215000.0,,
2017-03-31,2017-05-11,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,134000.0,,,188000.0,,,,,770000.0,,,90282000.0,,,90787.0,,,,11298000.0,8360000.0,,,,,,,,,,,,,,,,,,,,,,8079000.0,440000.0,,,,,,,,,,0.01,170000000.0,44214603.0,44214603.0,441000.0,,,,,,,,,,,,,424000.0,,,,,,,424000.0,2938000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.01,,0.01,,,,,,,,,,,,,,,,,,,,,,1091000.0,,,,,,,,,446000.0,,97000.0,,,,,,,,,,,,,,,,,,,,,629000.0,,0.0,,,,0.0,,,,,,11298000.0,322000.0,,,,,,,,,,,,,,440000.0,440000.0,645000.0,,645000.0,,,,349000.0,,,,,,,,,,,,,,,,281000.0,,,,,,,,,,349000.0,,,,,,,,0.0,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-79747000.0,,,,1440000.0,1440000.0,,,,,,,,,,,,,,,,,42000.0,,,,177000.0,,,,0.0,,,42000.0,,,42000.0,,,,,,,,,,10976000.0,0.0,,,,,,,,,,,,,,,,44215000.0,,44215000.0,,
2017-06-30,2017-08-10,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,363000.0,,,124000.0,,,,,,,,90282000.0,,,,,,,15648000.0,14833000.0,,,,,,,,,,,,,,,,,,,,,,11206000.0,,,,,,,,,,,0.01,170000000.0,44214603.0,44214603.0,441000.0,,,,,,,,,,,,,,,,,,,,2500000.0,815000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.09,0.09,0.09,0.35,,,,,,,,,,,,,,,,,,,,,6438000.0,,,,,,,,,2253000.0,,,,,,,,,,,1400000.0,,,,,,,,,,,,,,0.0,,,,,,,,,,15648000.0,487000.0,,,,,,,,,,,,,,,,4185000.0,,4185000.0,,,,337000.0,,,,,,,,,,,,,,,,127000.0,,,,,,,,,,337000.0,,,,,,3500000.0,,0.0,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,3500000.0,,,,,,,,,,,,,,,,,,,,,,,-75562000.0,,6775000.0,,6775000.0,6775000.0,,,,,,,,,,,,,,,,,42000.0,,,,,,,,,,,42000.0,,,42000.0,,,,,,,,,,15161000.0,,,,,,,,,,,,,,,,,44215000.0,44215000.0,44215000.0,,
2017-09-30,2017-11-09,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,213000.0,,,158000.0,,,,,,,,83650000.0,,,,,,,9053000.0,7904000.0,,,,,,,,,,,,,,,,,,,,,,4320000.0,,,,,,,,,,,0.01,170000000.0,44214603.0,44214603.0,441000.0,,,,,,,,,,,,,,,,,,,,2200000.0,1149000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,0.0,1.83,,,,,,,,,,,,,,,,,,,,,-184000.0,,,,,,,,,-337000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9053000.0,371000.0,,,,,,,,,,,,,,,,153000.0,,,,,,335000.0,,,,,,,,,,,,,,,,84000.0,,,,,,,,,,335000.0,,,,,,3500000.0,,0.0,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-75409000.0,,151000.0,,151000.0,151000.0,,,,,,,,,,,,,,,,,42000.0,,,,,,,,,,,42000.0,,,42000.0,,,,,,,,,,8682000.0,,,,,,,,,,,,,,,,,44215000.0,44215.0,44215000.0,,
2017-12-31,2018-03-21,10-K,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,225000.0,,,143000.0,142000.0,,,,,,,83649000.0,0.0,,,,,,9512000.0,7572000.0,,,,,,,,,,,,,,,,,,,,,,7478000.0,-161000.0,7478000.0,,,,,,,,,0.01,170000000.0,44214603.0,44214603.0,442000.0,,-1801000.0,,-1799000.0,,,,,,,,3362000.0,3362000.0,,332000.0,41339000.0,,,0.0,,0.0,,24399000.0,,0.0,16608000.0,,,41339000.0,,,,,,,,,,,,,,,,,6632000.0,,,,111000.0,,0.12,0.12,0.12,,0.35,,,,,,,,,,,,0.0,,,,,,,,7008000.0,,,,,,,,,1563000.0,,0.0,0.0,1940000.0,-14549000.0,16869000.0,,2453000.0,,0.0,-2379000.0,,970000.0,,1801000.0,-545000.0,15900000.0,,1940000.0,,-27000.0,-176000.0,,,0.0,,,,,,,,,,9512000.0,368000.0,,,,,,,,,,-6632000.0,,,,6471000.0,,5445000.0,,5445000.0,,,,1371000.0,,,,,,,,,,,,,,,1000.0,94000.0,,,,,,,,,,1371000.0,,,,,,3500000.0,,0.0,,,,6632000.0,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,3500000.0,,,,,,,,,,,,,,,,,,,,,,,-74947000.0,,8379000.0,,8379000.0,8379000.0,,,,,,,,,,,,,,,,,42000.0,3.11,,,177000.0,0.0,,,0.0,0.0,0.0,41787.0,3.11,0.0,42000.0,3.11,0.0,,,0.0,0.0,,,,9144000.0,0.0,,,,,,0.0,,,,,,,,,,44215000.0,44215000.0,44215000.0,,
2018-03-31,2018-05-10,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,313000.0,,,155000.0,,,,,,,,83649000.0,,,,,,,9300000.0,7360000.0,,,,,,,,,,,,,,,,,,,,,,7240000.0,-238000.0,,,,,,,,,,0.01,170000000.0,44214603.0,44214603.0,442000.0,,,,,,,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.01,-0.01,-0.01,,,,,,,,,,,,,,,,,,,,,,-311000.0,,,,,,,,,1000.0,,,,1940000.0,,,,,,,,,,,,,,,,,,,-74000.0,,0.0,,,,0.0,,,,,,9300000.0,468000.0,,,,,,,,,,0.0,,,,-238000.0,,-307000.0,,-312000.0,,,,326000.0,,,,,,,,,,,,,,,,120000.0,,,,,,,,,,326000.0,,,,,,,,,,,,0.0,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-75259000.0,,15000.0,,15000.0,15000.0,,,,,,,,,,,,,,,,,41787.0,,,,0.0,,,,0.0,,,41787.0,,,41787.0,,,,,,,,,,8837000.0,0.0,,,,,,,,,,,,,,,,44215000.0,,44215000.0,,
2018-06-30,2018-08-10,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,253000.0,,,126000.0,,,,253000.0,,,,83649000.0,,,41787000.0,,,,9010000.0,7070000.0,,,,,,,,,,,,,,,,,,,,,,6966000.0,,6966000.0,,,,,,,,,0.01,170000000.0,44214603.0,44214603.0,442000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.01,-0.01,-0.01,,,,,,,,,,,,,,,,,,,,,,-206000.0,,,,,,,,,0.0,,,,1940000.0,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,9010000.0,379000.0,,,,,,,,,,,,,,,,-206000.0,,-206000.0,,,,267000.0,-206000.0,,,,,,,,,,,,,,,104000.0,,,,,,,,,,267000.0,,,,,,,,,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-75460000.0,,61000.0,,,,,,,,,,,,0.0,,,,,,,,41787000.0,,,,,,,,,,,41787000.0,,,41787000.0,,,,,,,,,,8631000.0,,,,,,,,,,,,,,,,,44215000.0,,44215000.0,,
2018-09-30,2018-11-07,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,533000.0,,,90000.0,,,,,,,,83649000.0,,,41787000.0,,,,8734000.0,6794000.0,,,,,,,,,,,,,,,,,,,,,,6726000.0,,6726000.0,,,,,,,,,0.01,170000000.0,44214603.0,44214603.0,442000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.01,-0.01,-0.01,0.001,,,,,,,,,,,,,,,,,,,,,-519000.0,,,,,,,,,1000.0,,,,1940000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8734000.0,623000.0,,,,,,,,,,,,,,,,-520000.0,,-520000.0,,,,239000.0,-519000.0,,,,,,,,,,,,,,,68000.0,,,,,,,,,,239000.0,,,,,,,,,,,,,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-75980000.0,,-280000.0,54000.0,,,,,,,,,,,0.0,,,,,,,,41787.0,,,,,,,,,,,41787.0,,,41787.0,,,,,,,,,,8111000.0,,,,,,,,,,,,,,,,,44215000.0,44215.0,44215000.0,,
2018-12-31,2019-02-21,10-K,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,439000.0,,,78000.0,78000.0,,,439000.0,,,,83649000.0,0.0,,,,,,15510000.0,14540000.0,,,,,,,,,,,,,,,,,,,,,,6500000.0,-978000.0,6500000.0,-978000.0,,,,,,,,0.01,170000000.0,44214603.0,44214603.0,442000.0,,0.0,,6000.0,,,,,,,,0.0,0.0,,0.0,39007000.0,,,0.0,,,,22755000.0,,,16252000.0,,,39007000.0,,,,,,,,,,,,,,,,,,,0.0,,,,,0.13,,,0.21,,,,,,,,,,,,,,,,,,,,5855000.0,,,,,,,,,6000.0,,0.0,970000.0,970000.0,-2332000.0,0.0,,1229000.0,,248000.0,0.0,,505000.0,,0.0,214000.0,,,0.0,,-65000.0,-24000.0,,,,,,,,,,,,,15510000.0,517000.0,,,,,,,,,,0.0,,,,-978000.0,,5849000.0,,,,,,1063000.0,,,,,,,,,,,,,,,0.0,70000.0,,,,,,,,,,1063000.0,,,,,,,,,,,,0.0,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,0.0,,,,,,,,,,,,,,,,,,,-69098000.0,,6918000.0,,,,,,,,,,,,,,,,,,,,42.0,3.11,,,,,,0.0,,,0.0,41787.0,3.11,0.0,42.0,3.11,,,,,0.0,,,,14993000.0,,,,,,,,,,,,,16200000.0,,,,,44215000.0,,,
2019-03-31,2019-05-08,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,490000.0,,,95000.0,,,,,51000.0,,,80996000.0,,,41787.0,,,,12554000.0,11584000.0,,,,,,,,,,,,,,,,,,,,,,3558000.0,-2942000.0,3558000.0,-2942000.0,,,,,,,,0.01,170000000.0,44214603.0,44214603.0,442000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2653000.0,,,,,,-0.01,-0.01,-0.01,,,,,,,,,,,,,,,,,,,,,,-369000.0,,,,,,,,,2000.0,,2000000.0,970000.0,970000.0,,,,,,,,,,,,,,,,,,,-82000.0,,,,,,0.0,,,,,,12554000.0,585000.0,,,,,,,,,,-2653000.0,,,,-289000.0,,-371000.0,,-371000.0,,,,318000.0,-369000.0,,,,,,,,,,,,,,,56000.0,,,,,,,,,,318000.0,,,,,,,,,,,,2653000.0,,,,,,,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,-371000.0,,,,,,,,,,,,,,,,,-69469000.0,,-51000.0,,,,,,,,,,0.0,,0.0,,,,,,,,41787.0,,,,0.0,,,,0.0,,,41787.0,,,41787.0,,,,,,,,,,11969000.0,0.0,,,,,,,,,,,,,,,,44215.0,,44215.0,,
2019-06-30,2019-08-07,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,348000.0,,,107000.0,,,,142000.0,,,,80996000.0,,,41787.0,,,,12403000.0,11433000.0,,,,,,,,,,,,,,,,,,,,,,3367000.0,,3367000.0,,,,,,,,,0.01,170000000.0,44214603.0,44214603.0,442000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,970000.0,970000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12403000.0,455000.0,0.0,,,,,,,,,,,,,,,-21000.0,,-21000.0,,,,228000.0,-21000.0,708.0,,,,,,,,,,,,,,96000.0,,,,,,,,,,228000.0,,,,,,,,,,,,,,,,,,,0.01,3000000.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-69490000.0,,207000.0,,,,708000.0,,,,,,,,0.0,,,,,,,,41787.0,,,,,,,,,,,41787.0,,,41787.0,,,,,,,,,,11948000.0,,,,,,,,,,,,,,,,,44215.0,,44215.0,,
2019-09-30,2019-11-06,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,346000.0,,,101000.0,,,,,2000.0,,,75690000.0,,,41787.0,,,,12070000.0,11100000.0,,,,,,,,,,,,,,,,,,,,,,10016000.0,,10016000.0,,,,,,,,,0.01,170000000.0,44214603.0,44214603.0,442000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5306000.0,,5306000.0,5306000.0,,,-0.01,-0.01,-0.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,970000.0,970000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12070000.0,5753000.0,0.0,,,,,,,,,,,,,,,-325000.0,,-325000.0,,,,327000.0,-325000.0,,,,,,,,,,,,,,,114000.0,,,,,,,,,,327000.0,,,,,,,,,,,,,,,,,,,0.01,3000000.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-69815000.0,,2000.0,,,,,,,,,,,,0.0,,,,,,,,41787.0,,,,,,,,,,,41787.0,,,41787.0,,,,,,,,,,6317000.0,,,,,,,,,,,,,,,,,44215.0,,44215.0,,
2019-12-31,2020-02-19,10-K,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,324000.0,,,99000.0,81000.0,,,324000.0,324000.0,,,75690000.0,0.0,,,,,,6478000.0,5993000.0,,,,,,,,,,,,,,,,,,,,,,5446000.0,,5446000.0,-1054000.0,0.0,,,0.0,,,,0.01,170000000.0,44214603.0,44214603.0,442000.0,,0.0,,6000.0,,,,,,,,0.0,,0.0,,38865000.0,,,0.0,,,,23030000.0,,,15835000.0,,,38865000.0,,,,,,,,,,,,,,,,,7959000.0,,,,,,,-0.02,,,0.21,,,,0.0,,,,,,,,,,,,,,,,-973000.0,,,,,,,,,6000.0,,,485000.0,485000.0,-141000.0,,,-204000.0,,0.0,,,-65000.0,,,-115000.0,,,-970000.0,,21000.0,-8000.0,,,,,,,,,,,,,6478000.0,423000.0,,,,0.0,,,,,,-7959000.0,,,,6905000.0,,-979000.0,,-979000.0,,,,1180000.0,-973000.0,,,,,,,,,,,,,,18000.0,62000.0,,,,,,,,,,1180000.0,,,,,,,,,,,,7959000.0,,,,,,,0.01,2960000.0,0.0,0.0,0.0,,,,,115000.0,,,,0.0,,,,,0.0,,,,,,,,,,,,,,-70077000.0,,207000.0,,,,,,,,,,,,,,,,,,,,42000.0,2.93,,,,,,0.0,,,0.0,42000.0,2.93,0.0,42000.0,2.93,,,,,0.0,0.0,,,6055000.0,,,,,,,,,,,,,15800000.0,,,,,44215000.0,,,
2020-03-31,2020-04-30,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,322000.0,,,102000.0,,,,2000.0,,,,75690000.0,0.0,,41787.0,,,,6237000.0,6237000.0,,,,,,,,,,,,,,,,,,,,,,5144000.0,,5144000.0,-302000.0,,,,,,,,0.01,170000000.0,44214603.0,44214603.0,442000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,322000.0,-0.01,-0.01,-0.01,,,,,,,,,,,,,,,,,,,,,,-240000.0,,,,,,,,,2000.0,,0.0,970000.0,0.0,,,,,,,,,,,,,,,,,,,60000.0,,,,,,0.0,,,,,,6237000.0,424000.0,0.0,,,,,,,,,,,,,-302000.0,,-242000.0,,-242000.0,,,,242000.0,-240000.0,,,,,,,,,,,,,,,123000.0,,,,,,,,,,242000.0,,,,0.0,,,,,,,,,,,,,,0.0,0.01,3000000.0,0.0,0.0,,,,,,,,,,,,-242000.0,,,0.0,,,,,,,,,,,,,,-70319000.0,,2000.0,,,,,,,,,,0.0,,0.0,,,,,,,,41787.0,,,,0.0,,,,0.0,,,41787.0,,,41787.0,,,,,,,,,,5813000.0,0.0,,,,,,,,,,,,,,,,44215.0,44215.0,44215.0,,
2020-06-30,2020-07-29,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,314000.0,,,113000.0,,,,8000.0,,,,75690000.0,,,41787.0,,,,6004000.0,6004000.0,,,,,,,,,,,,,,,,,,,,,,5909000.0,,5909000.0,,,,,0.0,,,,0.01,170000000.0,44214603.0,44214603.0,442000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,314000.0,-0.01,-0.01,-0.01,,,,,,,,,,,,,,,,,,,,,,-236000.0,,,,,,,,,0.0,,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,6004000.0,427000.0,0.0,,,,,,,,,,,,,,,-236000.0,,-236000.0,,,,244000.0,-236000.0,729.0,,,,,,,,,,,,,,95000.0,,,,,,,,,,244000.0,,,,0.0,,,,,,,,,,,,,,0.0,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-70555000.0,,8000.0,,,,,,,,,,,,0.0,,,,,,,,41787000.0,,,,,,,,,,,41787000.0,,,41787000.0,,,,,,,,,,5577000.0,,,,,,,,,,,,,,,,,44215.0,,44215.0,,
2020-09-30,2020-11-09,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,306000.0,,,348000.0,,,,8000.0,,,,75690000.0,,,41787.0,,,,5824000.0,5824000.0,,,,,,,,,,,,,,,,,,,,,,5311000.0,,5311000.0,,,,,0.0,,,,0.01,170000000.0,44214603.0,44214603.0,442000.0,,,,,,,,,,,,,,457000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,306000.0,-0.01,-0.01,-0.01,,,,,,,,,,,,,,,,,,,,,,-407000.0,,,,,,,,,0.0,,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5824000.0,654000.0,0.0,,,,,,,,,,,,,,,-407000.0,,-407000.0,,,,415000.0,-407000.0,,,,,,,,,,,,,,,56000.0,,,,,,,,,,415000.0,,,,0.0,,,,,,,,,,,,,,0.0,0.01,3000000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-70962000.0,,8000.0,,,,,,,,,,,,0.0,,,,,,,,41787000.0,,,,,,,,,,,41787000.0,,,41787000.0,,,,,,,,,,5170000.0,,,,,,,,,,,,,,,,,44215.0,,44215.0,,
2020-12-31,2021-02-23,10-K,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,302000.0,,,110000.0,92000.0,,,,,,,78006000.0,0.0,,,,,,48232000.0,48232000.0,,,,,,,,,,,,,,,,,,,,,,48142000.0,,48142000.0,42696000.0,43600000.0,,,,,,,0.01,170000000.0,74214603.0,74214603.0,742000.0,,0.0,,7000.0,,,,,,,,0.0,,,,38193000.0,,,0.0,,,,23398000.0,,,14795000.0,,,38193000.0,,,,,,,,,,,,,,,,,460000.0,,,,,,-0.03,-0.03,-0.03,,0.21,,,,0.0,,,,,,,,,,,,,,,,-1304000.0,,,,,,,,,7000.0,,,,,-672000.0,,,-274000.0,,0.0,,,-86000.0,,,-22000.0,,,-970000.0,,11000.0,28000.0,,,,,,,,,,,,,48232000.0,412000.0,,,,,,,,,,43076000.0,,,,-380000.0,,-1311000.0,,-1771000.0,,,,1357000.0,-1305000.0,,,,,,,,,,,,,103000000.0,18000.0,59000.0,,,,,,,,,,1357000.0,,,,1000.0,,,,,,,,0.0,524000.0,,,,,460000.0,0.01,2960000.0,0.0,0.0,0.0,,43600000.0,,,,,,,0.0,,,,,0.0,,,,,,,,,,,,,,-71388000.0,,52000.0,,,,,,,,,,,,,,,,,,,,25000.0,1.31,,,17000.0,,,0.0,,,0.0,25000.0,1.31,0.0,25000.0,1.31,,,,,0.0,,,,7360000.0,,,,,,,,,,,,,14800000.0,,,,51100.0,51100000.0,51100.0,,3076000.0
2021-03-31,2021-05-04,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,329000.0,,,132000.0,,,,,,,,77500000.0,0.0,,25000.0,,,,48292000.0,48292000.0,,,,,,,,,,,,,,,,,,,,,,48187000.0,,48187000.0,45000.0,43600000.0,,,,,,,0.01,170000000.0,74214603.0,74214603.0,742000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,506000.0,,,,,,,-0.01,,,,,,,,,,,,,,,,,,,,,,,13000.0,,,,,,,,,2000.0,,,,,,,,,,,,,,,,,,,,,,,-34000.0,,,,,,0.0,,,,,,48292000.0,461000.0,0.0,,,,,,,,,,,,,45000.0,,11000.0,,-495000.0,,,,370000.0,11000.0,,,,,,,,,,,,,103000000.0,,40000.0,,,,,,,,,,370000.0,,,,2000.0,,,,,,,,,,,,,,506000.0,0.01,2960000.0,0.0,0.0,0.0,,,,,,,,,,,11000.0,,,0.0,,,,,,,,,,,,,,-71377000.0,,381000.0,,,,,,,,,,0.0,,0.0,,,,,,,,25000.0,,,,0.0,,,,0.0,,,25000.0,,,25000.0,,,,,,,,,,6865000.0,0.0,,,,,,,,,,,,,,,,,74215.0,74215.0,,
2021-06-30,2021-08-05,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,331000.0,,,103000.0,,,,,,,,76994000.0,,,41787.0,,,,48246000.0,,,,,,,,,,,,,,,,,,,,,,,48191000.0,,48191000.0,,43600000.0,,,,,,,0.01,170000000.0,74214603.0,74214603.0,742000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,506000.0,,,,,,-0.01,-0.01,-0.01,,,,,,,,,,,,,,,,,,,,,,-19000.0,,,,,,,,,0.0,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,48246000.0,434000.0,0.0,,,,,,,,,,,,,,,-19000.0,,-525000.0,,,,312000.0,-21000.0,,,,,,,,,,,,,103000000.0,,55000.0,,,,,,,,,,312000.0,,,,2000.0,,,,,,,,,,,,,,506000.0,0.01,2960000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-71396000.0,,291000.0,,,,,,,,,,,,0.0,,,,,,,,25000.0,,,,,,,,,,,25000.0,,,25000.0,,,,,,,,,,6340000.0,,,,,,,,,,,,,,,,,74215.0,,74215.0,,
2021-09-30,2021-11-05,10-Q,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,331000.0,,,46000.0,,,,,,,,76488000.0,,,41787.0,,,,47963000.0,,,,,,,,,,,,,,,,,,,,,,,47891000.0,,47891000.0,,43600000.0,,,,,,,0.01,170000000.0,74214603.0,74214603.0,742000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,506000.0,,,,,,-0.01,,-0.01,,,,,,,,,,,,,,,,,,,,,,-226000.0,,,,,,,,,0.0,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,47963000.0,377000.0,0.0,,,,,,,,,,,,,,,-226000.0,,-732000.0,,,,228000.0,-228000.0,,,,,,,,,,,,,103500000.0,,72000.0,,,,,,,,,,228000.0,,,,2000.0,,,,,,,,,,,,,,506000.0,0.01,2960000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-71622000.0,,0.0,,,,,,,,,,,,0.0,,,,,,,,25000.0,,,,,,,,,,,25000.0,,,25000.0,,,,,,,,,,5608000.0,,,,,,,,,,,,,,,,,74215.0,,74215.0,,
2021-12-31,2022-02-25,10-K,"Enzon Pharmaceuticals,Â Inc.",ENZN,CIK0000727510,USD,331000.0,,,72000.0,61000.0,,,29000.0,,,,75983000.0,0.0,,,,,,47754000.0,,,,,,,,,,,,,,,,,,,,,,,47641000.0,,47641000.0,-501000.0,,,,,,,,0.01,170000000.0,74214603.0,74214603.0,742000.0,,0.0,,7000.0,,,,,,,,0.0,,,,37310000.0,,,0.0,,,,23530000.0,,,13780000.0,,,37310000.0,,,,,,,,,,,,,,,,,2023000.0,,,,,,-0.03,,-0.03,,0.21,1.0,,,0.0,,,,,,,,,,,,,,,,-462000.0,,,,,,,,,7000.0,,,,,-884000.0,,,-97000.0,,,,,-28000.0,,,29000.0,,,0.0,,-38000.0,23000.0,,,,,,,,,,,,,47754000.0,403000.0,,,,,,,,,,0.0,,,,-501000.0,,-469000.0,,-2492000.0,,,,1170000.0,-469000.0,,,,,,,,,,,,,103400000.0,11000.0,85000.0,,,,,,,,,,1170000.0,,,,7000.0,,,,,,,,0.0,0.0,,,,,2023000.0,0.01,2960000.0,0.0,0.0,,,0.0,,,,,,,0.0,,,,,0.0,,,,,,,,,,,,,,-71857000.0,,701000.0,,,,,,,,,,,,,,,,,,,,25000.0,1.31,,25000.0,,,,0.0,,,0.0,25000.0,1.31,0.0,25000.0,1.31,,,,,0.0,,,,4868000.0,,,,,,,,,,,,,,,,,74215.0,,74215.0,,
